Literature DB >> 6179881

Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients.

T Yoneyama, A Hagiwara, M Hara, H Shimojo.   

Abstract

A close relationship was demonstrated by oligonucleotide fingerprinting between genomes of the poliovirus type 2 Sabin vaccine strain and recent isolates from paralytic cases associated with vaccination in Japan. The oligonucleotide maps of isolates from an agammaglobulinemic patient, who continued to excrete poliovirus type 2 for 3.5 years after the administration of oral vaccine, showed that the genomic alteration proceeded gradually, retaining the majority of the oligonucleotides characteristic of the vaccine strain for a long period, indicating vaccine origin for the isolates. The final isolate at month 41, however, lost the majority of these oligonucleotides. The heterologous antigenic relationship between the final isolate and the previous isolates was also observed. The serial alteration in electrophoretic mobility of the major structural proteins (VP1, VP2, and VP3) was observed throughout the excreting period. These results indicate that the population of the virus in this individual changed markedly during the last short period (about 3 months), in which the treatment with secretory immunoglobulin A was carried out. Genome comparisons in oligonucleotide maps show that some oligonucleotides in the genome of the vaccine strain are highly mutable after passage in humans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179881      PMCID: PMC347488          DOI: 10.1128/iai.37.1.46-53.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  "Fingerprinting" high molecular weight RNA by two-dimensional gel electrophoresis: application to poliovirus RNA.

Authors:  Y F Lee; E Wimmer
Journal:  Nucleic Acids Res       Date:  1976-07       Impact factor: 16.971

2.  Characterization of poliovirus isolates in Japan after the mass vaccination with live oral poliomyelitis vaccine (Sabin).

Authors:  I Tagaya; C Nakao; M Hara; S Yamadera
Journal:  Bull World Health Organ       Date:  1973-05       Impact factor: 9.408

3.  Antigenic characterization of poliovirus strains by neutralization kinetic studies and the modified Wecker technique.

Authors:  C Nakao
Journal:  Jpn J Med Sci Biol       Date:  1969-08

4.  Serodifferentiation of poliovirus strains. I. Modified Wecker test on types 1 and 2 poliovirus strains.

Authors:  T Kitahara; M Hara; C Nakao; K Soda; I Tagaya
Journal:  Jpn J Med Sci Biol       Date:  1967-10

5.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

6.  Poliomyelitis in hypogammaglobulinemics.

Authors:  H V Wyatt
Journal:  J Infect Dis       Date:  1973-12       Impact factor: 5.226

7.  Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child.

Authors:  L E Davis; D Bodian; D Price; I J Butler; J H Vickers
Journal:  N Engl J Med       Date:  1977-08-04       Impact factor: 91.245

8.  Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration.

Authors:  M Hara; Y Saito; T Komatsu; H Kodama; W Abo; S Chiba; T Nakao
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

9.  Genetic variation of neurotropic and non-neurotropic murine coronaviruses.

Authors:  H Wege; J R Stephenson; M Koga; H Wege; V ter Meulen
Journal:  J Gen Virol       Date:  1981-05       Impact factor: 3.891

10.  Structural proteins of poliovirus type 2 isolates.

Authors:  T Yoneyama; A Hagiwara; M Hara
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

View more
  11 in total

1.  Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.

Authors:  Chen-Fu Yang; Tary Naguib; Su-Ju Yang; Eman Nasr; Jaume Jorba; Nahed Ahmed; Ray Campagnoli; Harrie van der Avoort; Hiroyuki Shimizu; Tetsuo Yoneyama; Tatsuo Miyamura; Mark Pallansch; Olen Kew
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

2.  Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.

Authors:  Chen-Fu Yang; Hour-Young Chen; Jaume Jorba; Hui-Chih Sun; Su-Ju Yang; Hsiang-Chi Lee; Yhu-Chering Huang; Tzou-Yien Lin; Pei-Jer Chen; Hiroyuki Shimizu; Yorihiro Nishimura; Andi Utama; Mark Pallansch; Tatsuo Miyamura; Olen Kew; Jyh-Yuan Yang
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Persistence of echovirus 6 in cloned human cells.

Authors:  J P Gibson; V F Righthand
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

4.  Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies.

Authors:  E A Emini; S Y Kao; A J Lewis; R Crainic; E Wimmer
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

5.  Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient.

Authors:  O M Kew; R W Sutter; B K Nottay; M J McDonough; D R Prevots; L Quick; M A Pallansch
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Characterization of genetic changes occurring in attenuated poliovirus 2 during persistent infection in mouse central nervous systems.

Authors:  E J Rozhon; A K Wilson; B Jubelt
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

7.  Genetic and phenotypic characteristics of enterovirus 71 isolates from patients with encephalitis and with hand, foot and mouth disease.

Authors:  A Hagiwara; T Yoneyama; S Takami; I Hashimoto
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  Vaccine associated paralytic poliomyelitis.

Authors:  S K Mittal; Joseph L Mathew
Journal:  Indian J Pediatr       Date:  2003-07       Impact factor: 1.967

9.  Natural variation of poliovirus neutralization epitopes.

Authors:  R Crainic; P Couillin; B Blondel; N Cabau; A Boué; F Horodniceanu
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.

Authors:  Elena A Cherkasova; Ekaterina A Korotkova; Maria L Yakovenko; Olga E Ivanova; Tatyana P Eremeeva; Konstantin M Chumakov; Vadim I Agol
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.